Ad-RTS-hIL-12
ATI001-102
Phase 1 mab completed
Quick answer
Ad-RTS-hIL-12 for Glioblastoma Multiforme is a Phase 1 program (mab) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Glioblastoma Multiforme
- Phase
- Phase 1
- Modality
- mab
- Status
- completed